Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient

Clinical trial NCT02069418 · UNKNOWN

Trial details

NCT number: NCT02069418
Sponsor: University Hospital, Angers
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent No EGFR Activating Mutation

Start date: 2014-02-01
Primary completion: 2016-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.